XMTR Quote, Financials, Valuation and Earnings

LegalZoom.com has a net margin of -6.66% compared to Xometry's net margin of 7.95%. Xometry's return on equity of -15.74% beat LegalZoom.com's return on equity of 27.2%.

Xometry has a consensus price target of $35.50, signalling upside risk potential of 60.85%. On the other hand LegalZoom.com has an analysts' consensus of $9.86 which suggests that it could grow by 24.62%. Given that Xometry has higher upside potential than LegalZoom.com, analysts believe Xometry is more attractive than LegalZoom.com.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LegalZoom.com has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LegalZoom.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. LegalZoom.com pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $148.5M, which are smaller than LegalZoom.com quarterly revenues of $161.7M. Xometry's net income of -$9.9M is lower than LegalZoom.com's net income of $12.9M. Notably, Xometry's price-to-earnings ratio is -- while LegalZoom.com's PE ratio is 49.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 1.99x versus 2.12x for LegalZoom.com. Usually stocks with elevated PS ratios are considered overvalued.

Rosinbomb has a net margin of -6.66% compared to Xometry's net margin of --. Xometry's return on equity of -15.74% beat Rosinbomb's return on equity of --.

Xometry has a consensus price target of $35.50, signalling upside risk potential of 60.85%. On the other hand Rosinbomb has an analysts' consensus of -- which suggests that it could fall by --. Given that Xometry has higher upside potential than Rosinbomb, analysts believe Xometry is more attractive than Rosinbomb.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Rosinbomb has a beta of 1.164, suggesting its more volatile than the S&P 500 by 16.4%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Rosinbomb offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. Rosinbomb pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $148.5M, which are larger than Rosinbomb quarterly revenues of --. Xometry's net income of -$9.9M is higher than Rosinbomb's net income of --. Notably, Xometry's price-to-earnings ratio is -- while Rosinbomb's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 1.99x versus -- for Rosinbomb. Usually stocks with elevated PS ratios are considered overvalued.

Team has a net margin of -6.66% compared to Xometry's net margin of -3.37%. Xometry's return on equity of -15.74% beat Team's return on equity of -165.8%.

Xometry has a consensus price target of $35.50, signalling upside risk potential of 60.85%. On the other hand Team has an analysts' consensus of -- which suggests that it could grow by 550%. Given that Team has higher upside potential than Xometry, analysts believe Team is more attractive than Xometry.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Team has a beta of 1.598, suggesting its more volatile than the S&P 500 by 59.759%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Team offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. Team pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $148.5M, which are smaller than Team quarterly revenues of $213.3M. Xometry's net income of -$9.9M is lower than Team's net income of -$7.2M. Notably, Xometry's price-to-earnings ratio is -- while Team's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 1.99x versus 0.10x for Team. Usually stocks with elevated PS ratios are considered overvalued.

UL Solutions has a net margin of -6.66% compared to Xometry's net margin of 10.96%. Xometry's return on equity of -15.74% beat UL Solutions's return on equity of 41.02%.

Xometry has a consensus price target of $35.50, signalling upside risk potential of 60.85%. On the other hand UL Solutions has an analysts' consensus of $59.15 which suggests that it could grow by 7.33%. Given that Xometry has higher upside potential than UL Solutions, analysts believe Xometry is more attractive than UL Solutions.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UL Solutions has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UL Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.13 per share. Xometry pays -- of its earnings as a dividend. UL Solutions pays out 30.68% of its earnings as a dividend. UL Solutions's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Xometry quarterly revenues are $148.5M, which are smaller than UL Solutions quarterly revenues of $739M. Xometry's net income of -$9.9M is lower than UL Solutions's net income of $81M. Notably, Xometry's price-to-earnings ratio is -- while UL Solutions's PE ratio is 34.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 1.99x versus 3.86x for UL Solutions. Usually stocks with elevated PS ratios are considered overvalued.